Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Antares Pharma And Uman Pharma Enter Collaboration for VIBEXT MTX Novel Injectable Methotrexate Product

By Pharmaceutical Processing | April 27, 2010

Antares Pharma, Inc., a company involved in self-injection drug delivery technology and Uman Pharma, a manufacturer of injectable pharmaceutical products based in Quebec, Canada, today announced the formation of a strategic alliance covering Antares’ VIBEX(TM) MTX.

Under the terms of the agreement Antares and Uman will invest jointly to develop and commercialize VIBEX(TM) MTX, Antares’ novel pressure-assisted, injection device, containing methotrexate (MTX) for rheumatoid arthritis and related autoimmune conditions in the US and Canada. Antares will lead the clinical development program, FDA regulatory submissions, and retains rights to commercialize the VIBEX(TM) MTX product outside of Canada. Uman will perform formulation development and manufacturing activities to support the registration of VIBEX(TM) MTX and supply methotrexate in prefilled syringes to Antares for the US market. Uman received an exclusive license to commercialize the VIBEX(TM) MTX product in Canada. The companies intend to work together to commercialize the VIBEX(TM) MTX product in other territories.

“We are pleased to announce this partnership with such a strong partner as Uman Pharma to develop methotrexate for use in our VIBEX(TM) injection device,” stated Paul K. Wotton, Ph.D., President and Chief Executive Officer. “Our market research with physicians shows that most would use methotrexate by the parenteral route more frequently, thereby accelerating market growth, if provided with a simple-to-use and secure system that enabled patients to reliably and comfortably self-inject the drug. We believe that physicians and patients alike will welcome our VIBEX(TM) injection system for administering parenteral methotrexate.”

“We are very excited and proud to be associated with Antares Pharma for the development and manufacturing of methotrexate in pre-filled syringes and look forward to the anticipated launch of the VIBEX(TM) delivery technology for the US and Canadian markets,” stated Uman Pharma’s Chief Executive Officer, Mr. Sylvain Duvernay. “Entering this strategic alliance represents an important milestone for us and it is in line with our vision and our mission to bring top-quality products, adding a human touch to make a true difference in patients’ lives.”

 

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE